GO
Loading...

Lilly Defends Zyprexa Allegations

Monday, 18 Dec 2006 | 12:48 PM ET

Eli Lilly fires back at The New York Times after the paper ran two unfavorable stories about the company's lucrative Schizophrenia drug, Zyprexa. Mike Huckman, CNBC Pharmaceuticals Reporter, has the details.